Form 8-K - Current report:
SEC Accession No. 0001628280-25-036705
Filing Date
2025-07-30
Accepted
2025-07-30 16:04:34
Documents
50
Period of Report
2025-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prme-20250730.htm   iXBRL 8-K 33727
2 EX-99.1 jul_2025xcorpxpresentati.htm EX-99.1 46017
6 jul_2025xcorpxpresentati001.jpg GRAPHIC 62839
7 jul_2025xcorpxpresentati002.jpg GRAPHIC 289111
8 jul_2025xcorpxpresentati003.jpg GRAPHIC 113502
9 jul_2025xcorpxpresentati004.jpg GRAPHIC 116876
10 jul_2025xcorpxpresentati005.jpg GRAPHIC 147042
11 jul_2025xcorpxpresentati006.jpg GRAPHIC 123721
12 jul_2025xcorpxpresentati007.jpg GRAPHIC 156736
13 jul_2025xcorpxpresentati008.jpg GRAPHIC 137956
14 jul_2025xcorpxpresentati009.jpg GRAPHIC 77938
15 jul_2025xcorpxpresentati010.jpg GRAPHIC 104249
16 jul_2025xcorpxpresentati011.jpg GRAPHIC 42920
17 jul_2025xcorpxpresentati012.jpg GRAPHIC 160220
18 jul_2025xcorpxpresentati013.jpg GRAPHIC 163838
19 jul_2025xcorpxpresentati014.jpg GRAPHIC 120917
20 jul_2025xcorpxpresentati015.jpg GRAPHIC 48370
21 jul_2025xcorpxpresentati016.jpg GRAPHIC 147497
22 jul_2025xcorpxpresentati017.jpg GRAPHIC 99394
23 jul_2025xcorpxpresentati018.jpg GRAPHIC 122636
24 jul_2025xcorpxpresentati019.jpg GRAPHIC 54975
25 jul_2025xcorpxpresentati020.jpg GRAPHIC 163887
26 jul_2025xcorpxpresentati021.jpg GRAPHIC 119861
27 jul_2025xcorpxpresentati022.jpg GRAPHIC 144128
28 jul_2025xcorpxpresentati023.jpg GRAPHIC 40072
29 jul_2025xcorpxpresentati024.jpg GRAPHIC 162701
30 jul_2025xcorpxpresentati025.jpg GRAPHIC 123850
31 jul_2025xcorpxpresentati026.jpg GRAPHIC 149287
32 jul_2025xcorpxpresentati027.jpg GRAPHIC 49251
33 jul_2025xcorpxpresentati028.jpg GRAPHIC 153483
34 jul_2025xcorpxpresentati029.jpg GRAPHIC 147781
35 jul_2025xcorpxpresentati030.jpg GRAPHIC 105939
36 jul_2025xcorpxpresentati031.jpg GRAPHIC 45768
37 jul_2025xcorpxpresentati032.jpg GRAPHIC 122750
38 jul_2025xcorpxpresentati033.jpg GRAPHIC 169080
39 jul_2025xcorpxpresentati034.jpg GRAPHIC 166715
40 jul_2025xcorpxpresentati035.jpg GRAPHIC 45801
41 jul_2025xcorpxpresentati036.jpg GRAPHIC 100742
42 jul_2025xcorpxpresentati037.jpg GRAPHIC 128574
  Complete submission text file 0001628280-25-036705.txt   6325608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20250730.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20250730_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20250730_pre.xml EX-101.PRE 13055
52 EXTRACTED XBRL INSTANCE DOCUMENT prme-20250730_htm.xml XML 2913
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 251166946
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)